Non-human primate study results demonstrate improvements in skeletal and cardiac muscle delivery efficacy, safety potential, human translatability, and manufacturability over prior AAV capsids ...
WATERTOWN, Mass., November 11, 2025--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene ...
The MarketWatch News Department was not involved in the creation of this content. -- Non-human primate study results demonstrate improvements in skeletal and cardiac muscle delivery efficacy, safety ...
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback